{"id":"NCT02754882","sponsor":"Samsung Bioepis Co., Ltd.","briefTitle":"A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer","officialTitle":"A Phase 3, Randomised, Double-blind Study to Compare the Efficacy, Safety, PK and Immunogenicity Between SB8 (Proposed Bevacizumab Biosimilar) and Avastin® in Subjects With Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-07-05","primaryCompletion":"2018-01-24","completion":"2018-10-09","firstPosted":"2016-04-28","resultsPosted":"2024-12-16","lastUpdate":"2024-12-16"},"enrollment":763,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lung Cancer","Non-small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin®"]},{"type":"DRUG","name":"SB8","otherNames":["SB8 (A proposed bevacizumab biosimilar)"]},{"type":"DRUG","name":"Carboplatin","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":["Taxol"]}],"arms":[{"label":"Bevacizumab (Avastin)","type":"ACTIVE_COMPARATOR"},{"label":"SB8 (A proposed bevacizumab biosimilar)","type":"EXPERIMENTAL"}],"summary":"This study is designed to establish biosimilarity of SB8, a proposed biosimilar product of bevacizumab, to EU-sourced bevacizumab, in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC).","primaryOutcome":{"measure":"Percentage of Participants With Best Overall Response (Best Overall Response Rate[ORR]) by 24 Weeks","timeFrame":"24 weeks from randomisation","effectByArm":[{"arm":"Bevacizumab (Avastin)","deltaMin":42.8,"sd":null},{"arm":"SB8 (A Proposed Bevacizumab Biosimilar)","deltaMin":47.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":105,"countries":["Belarus","Georgia","Germany","Hungary","Poland","Romania","Russia","Serbia","South Korea","Spain","Taiwan","Thailand","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":81,"n":380},"commonTop":["Alopecia","Anaemia","Nausea","Neutropenia","Thrombocytopenia"]}}